Arcutis Biotherapeutics, Inc. (ARQT)
27.53
-0.85
(-3.00%)
USD |
NASDAQ |
Nov 12, 16:00
27.04
-0.49
(-1.78%)
After-Hours: 06:58
Arcutis Biotherapeutics Price : 27.53 for Nov. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 28.24 | 28.94 | 27.45 | 27.53 | 1.895M |
| Nov 11, 2026 | 27.50 | 28.65 | 27.20 | 28.38 | 2.491M |
| Nov 10, 2026 | 25.87 | 27.62 | 25.82 | 27.38 | 2.224M |
| Nov 09, 2026 | 25.65 | 26.43 | 25.23 | 26.20 | 2.764M |
| Nov 06, 2026 | 26.70 | 27.09 | 25.29 | 25.55 | 3.262M |
| Nov 05, 2026 | 29.00 | 29.49 | 25.78 | 27.00 | 7.602M |
| Nov 04, 2026 | 32.88 | 34.80 | 31.87 | 34.05 | 2.747M |
| Nov 03, 2026 | 31.32 | 32.39 | 31.26 | 32.00 | 1.617M |
| Nov 02, 2026 | 32.07 | 32.24 | 31.20 | 31.26 | 1.515M |
| Oct 30, 2026 | 32.34 | 32.69 | 31.67 | 32.07 | 1.884M |
| Oct 29, 2026 | 31.40 | 32.08 | 31.15 | 31.97 | 1.753M |
| Oct 28, 2026 | 31.50 | 32.00 | 31.39 | 31.45 | 1.670M |
| Oct 27, 2026 | 31.40 | 32.11 | 31.18 | 31.68 | 2.224M |
| Oct 26, 2026 | 31.41 | 32.26 | 31.35 | 31.81 | 1.548M |
| Oct 23, 2026 | 32.13 | 32.13 | 30.91 | 31.20 | 1.894M |
| Oct 22, 2026 | 31.68 | 32.50 | 31.35 | 32.20 | 2.076M |
| Oct 21, 2026 | 32.64 | 32.94 | 31.65 | 31.87 | 1.689M |
| Oct 20, 2026 | 31.89 | 33.30 | 31.75 | 32.82 | 4.491M |
| Oct 19, 2026 | 29.41 | 33.01 | 28.99 | 31.89 | 5.796M |
| Oct 16, 2026 | 29.18 | 29.37 | 28.15 | 28.82 | 1.802M |
| Oct 15, 2026 | 26.93 | 29.46 | 26.93 | 29.10 | 3.956M |
| Oct 14, 2026 | 26.01 | 26.94 | 25.86 | 26.41 | 1.647M |
| Oct 13, 2026 | 25.93 | 26.57 | 25.60 | 26.09 | 1.889M |
| Oct 12, 2026 | 26.54 | 26.82 | 25.97 | 26.22 | 1.557M |
| Oct 09, 2026 | 24.50 | 26.97 | 24.30 | 26.58 | 1.732M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 18.14 |
| ADMA Biologics, Inc. | 13.24 |
| Alnylam Pharmaceuticals, Inc. | 156.65 |
| Anika Therapeutics, Inc. | 13.81 |
| Savara, Inc. | 4.72 |
Price Related Metrics
| PE Ratio | 127.69 |
| PS Ratio | 7.276 |
| Price to Book Value | 14.22 |
| Price to Free Cash Flow | 61.99 |
| Earnings Yield | 0.78% |
| Market Cap | 3.469B |
| Operating PE Ratio | 105.25 |
| Normalized PE Ratio | 127.39 |